Shares of Vanda Pharmaceuticals Has Risen Above Previous 52-Week High
Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) traded today at $18.80, breaking its 52-week high. This new high was reached on below average trading volume as 395,000 shares traded hands, while the average 30-day volume is approximately 1.4 million shares.
In the past 52 weeks, Vanda Pharmaceuticals share prices have been bracketed by a low of $3.80 and a high of $18.80 and are now at $18.55, 388% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 1.3% while the 50-day MA has advanced 2.3%.
Vanda Pharmaceuticals (NASDAQ:VNDA) has potential upside of 26.7% based on a current price of $18.55 and analysts' consensus price target of $23.50. Vanda Pharmaceuticals shares have support at the 50-day moving average (MA) of $13.64 and additional support at the 200-day MA of $11.12.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of a portfolio of clinical-stage, small molecule product candidates for central nervous system disorders.
SmarTrend recommended that subscribers consider buying shares of Vanda Pharmaceuticals on December 30th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $12.50. Since that recommendation, shares of Vanda Pharmaceuticals have risen 44.3%. We continue to monitor VNDA for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows vanda pharmaceuticals